CLINICAL OUTCOMES OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH EITHER DULOXETINE OR SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN MEXICO

被引：0
|
作者：
Hong, J. [1 ]
Novick, D. [1 ]
Montgomery, W. [2 ]
Duenas, H. [3 ]
Peng, X. [4 ]
Kadziola, Z. [5 ]
Haro, J. M. [6 ]
机构：
[1] Eli Lilly & Co, Windlesham, Surrey, England
[2] Eli Lilly Australia Pty Ltd, West Ryde, Australia
[3] Eli Lilly Mexico, Mexico City, DF, Mexico
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Eli Lilly GmbH, Vienna, Austria
[6] Univ Barcelona, CIBERSAM, Barcelona, Spain
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2083
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A694 / A694
页数：1
相关论文
共 50 条
  • [1] Treatment effectiveness for patients major depressive disorder treated with either duloxetine or selective serotonin reuptake inhibitors in Middle East
    Novick, Diego
    Hong, Jihyung
    Montgomery, William
    Duenas, Hector
    Gado, Magdy
    Maria Haro, Josep
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 : 30 - 30
  • [2] Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors
    Sheehan, David V.
    Mancini, Michele
    Wang, Jianing
    Berggren, Lovisa
    Cao, Haijun
    Jose Duenas, Hector
    Yue, Li
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (01) : 53 - 63
  • [3] Efficacy of duloxetine and selective serotonin reuptake inhibitors - Comparisons as assessed by remission rates in patients with major depressive disorder
    Thase, Michael E.
    Pritchett, Yili Lu
    Ossanna, Melissa J.
    Swindle, Ralph W.
    Xu, Jimmy
    Detke, Michael J.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (06) : 672 - 676
  • [4] Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
    Huang, Jia
    Wang, Yun
    Chen, Jun
    Zhang, Yanlei
    Yuan, Zheng
    Yue, Li
    Maria Haro, Josep
    Victoria Moneta, Maria
    Novick, Diego
    Fang, Yiru
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2473 - 2484
  • [5] Plasma Amino Acid Profiling in Major Depressive Disorder Treated With Selective Serotonin Reuptake Inhibitors
    Woo, Hye-In
    Chun, Mi-Ryung
    Yang, Jeong-Soo
    Lim, Shinn-Won
    Kim, Min-Ji
    Kim, Seon-Woo
    Myung, Woo-Jae
    Kim, Doh-Kwan
    Lee, Soo-Youn
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (05) : 417 - 424
  • [6] Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder
    Bakish, D
    Cavazzoni, P
    Chudzik, J
    Ravindran, A
    Hrdina, PD
    [J]. BIOLOGICAL PSYCHIATRY, 1997, 41 (02) : 184 - 190
  • [7] Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland
    Benedict, Agnes
    Arellano, Jorge
    De Cock, Erwin
    Baird, Jessamy
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2010, 120 (1-3) : 94 - 104
  • [8] The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder
    Clevenger, Steven S.
    Malhotra, Devvrat
    Dang, Jonathan
    Vanle, Brigitte
    IsHak, Waguih William
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2018, 8 (01) : 49 - 58
  • [9] Interpersonal sensitivity and response to selective serotonin reuptake inhibitors in patients with acute major depressive disorder
    Peters, Evyn M.
    Yilmaz, Orhan
    Li, Cindy
    Balbuena, Lloyd
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 355 : 422 - 425
  • [10] Selective serotonin reuptake inhibitors:: use in children and adolescents with major depressive disorder
    Jimenez-Arriero, M. A.
    Fernandez, I.
    Vidal, J.
    Herraez, C.
    Parellada, M.
    Cruz, M. A.
    Perez-Cayuela, P.
    Ausejo, M.
    [J]. ACTAS ESPANOLAS DE PSIQUIATRIA, 2007, 35 (05): : 342 - 350
12345